Tag Archives: total knee arthroplasty
Total Knee Arthroplasty with Constrained Implants in Patients with Neuropathic Arthropathy of the Knee Provides Good Functional Outcomes, and is Not Associated with a High Rate of Complications
Vol 10 | Issue 1 | January-June 2024 | page: 46-49 | Arpit Mutha, Parag Sancheti, Sunny Gugale, Kailash Patil, Darshan Sonawane, Ashok Shyam
https://doi.org/10.13107/jmt.2024.v10.i01.220
Author: Arpit Mutha [1], Parag Sancheti [1], Sunny Gugale [1], Kailash Patil [1], Darshan Sonawane [1], Ashok Shyam [1]
[1] Department of Orthopaedics, Sancheti Hospital, Shivajinagar, Pune, Maharashtra, India.
Address of Correspondence
Dr. Arpit Mutha,
Department of Orthopaedics, Sancheti Hospital, Shivajinagar, Pune, Maharashtra, India.
E-mail: arpitmutha97@gmail.com
Abstract
Neuropathic (Charcot) arthropathy is a progressive degenerative condition that leads to the destruction and collapse of weight bearing joints, often accompanied by large effusions that compromise supporting soft tissue structures. Historically, neurosyphilis was the primary cause, but today, poorly controlled diabetes mellitus is the most common underlying factor. Total Knee Arthroplasty (TKA) was considered a contraindication in neuropathic arthropathy due to the risk of complications such as periprosthetic joint infection, tibiofemoral dislocation, and periprosthetic fracture. However, recent studies suggest that using constrained implants, along with advanced surgical techniques, provide improved functional outcomes in this challenging patient population.
This study aims to evaluate the functional outcomes and complication rates of TKA with constrained prostheses in patients with neuropathic arthropathy, addressing the gap in existing literature that is primarily based on older techniques, small sample sizes and a short follow up period. Data of 25 patients from 2018-2023 who have undergone TKA with constrained implants and with inclusion and exclusion criteria will be collected. Primary outcomes, i.e., range of motion (ROM) and pain scores, will be assessed using paired t-tests, while the Kaplan-Meier method will estimate implant survival. Secondary outcomes, i.e., functional scores and complication rates, will be analyzed with descriptive and inferential statistics.
Results of existing studies indicate that while constrained prostheses offer good functional outcomes, they are associated with a high rate of complications. These results highlight the need for careful patient selection and personalized treatment strategies. Future research should focus on larger sample sizes and long-term follow-up studies to refine patient selection criteria, improve surgical planning, and explore innovative implant designs to minimize complications. This study could contribute to the advancement of clinical knowledge and may influence treatment guidelines for managing neuropathic arthropathy, potentially improving patient outcomes and surgical decision-making.
Keywords: Neuropathic arthropathy, Charcot joint, total knee arthroplasty, constrained implants, functional outcomes, complication rates.
Background and Rationale
Neuropathic (Charcot) arthropathy is a progressive degenerative process leading to the destruction and collapse of the weight-bearing surface of joints, as well as the formation of large effusions that stretch supporting soft-tissue structures [1]. Historically, the primary underlying reason for loss of nociception was neurosyphilis. Today the most common cause of Neuropathy is long-standing and poorly controlled Diabetes Mellitus (DM) [2].
The diagnosis was previously considered an absolute contraindication to Total Knee Arthroplasty. Arthrodesis was used for neuropathic arthropathy with severe deformity and instability, showing good clinical outcomes [3]. However, a few cases reported complications like fractures and infections. Fused knees were also susceptible to trauma [3].
The outcome of total knee arthroplasty (TKA) in the Charcot joint is likely to be less favourable because of the unstable neurologic status; development of ataxia; and severe joint destruction, bone defects, and deformity[4] .
Total Knee Arthroplasty in patients with Neuropathic Arthropathy has shown a high rate of complications like periprosthetic joint infection (PJI), tibiofemoral dislocation, and periprosthetic fracture [2, 5, 6] with one study showing 47% complication rates, majority of them being aseptic loosening and poor functional outcomes [5].
However, more recent reports have described satisfactory outcomes with the use of increased constraint, stems, augments, and revision-type TKA components [2, 5, 6, 7].
There is limited literature that describes the long-term functional outcomes of patients with Neuropathy treated with constrained prosthesis. They are based on older surgical techniques and implant designs. Very few of the existing studies have a large sample size. Our study will assess the functional outcomes of doing TKA with constrained prosthesis in patients with Neuropathic Arthropathy and whether these results have changed as compared to older literature.
Our study aims to address the gap that exists in determining whether TKA with constrained prosthesis has good functional outcomes in patients with Neuropathy.
Literature review
Three studies [2, 5, 6] on Total Knee Arthroplasty (TKA) in patients with neuropathic arthropathy were reviewed. Across these studies, a total of 67 TKAs were performed in 46 patients, with follow-up periods ranging from 5 to 22 years. The number of knees treated varied from 11 to 37. All the studies reported fair to good functional outcomes. The mean range of motion (ROM) improvements differed significantly, from a decrease of 4° [6] to an increase of 19° [2], with an overall average improvement of 8.5°. Functional outcomes, measured by various scoring systems, showed an average increase of 42.5 points, ranging from a low of 37 to 82 points [2] to a high of 44.9 to 95.0 points [5].
The studies reported high complication rates, varying from 27% [2] to 47% [5] with an average complication rate of approximately 30.7%. Major complications included aseptic loosening, dislocations, infections, and fractures, often necessitating additional surgeries such as revisions, arthrodesis, or amputations. The strength of these studies lies in their focus on a challenging patient population with advanced joint pathology and their use of diverse follow-up periods to assess outcomes. Moreover, they have incorporated advanced surgical techniques and modern implants, providing insights into the potential of TKA for neuropathic arthropathy.
The limitations of these studies are small sample sizes, retrospective designs, and the absence of control groups, which limit the generalizability and robustness of their findings. Additionally, the variability in surgical approaches and the use of different prostheses add complexity to interpreting the overall effectiveness of TKA in this patient population.
Building on the findings of these studies, our hypothesis aims to address the gaps in current knowledge by evaluating the functional outcomes of TKA with constrained prostheses in a contemporary setting using more standardized surgical techniques and implant designs. Unlike previous studies, which often relied on older methods or lacked sufficient sample sizes, our study seeks to provide a more comprehensive analysis of the efficacy and safety of constrained prostheses in treating neuropathic arthropathy, thus contributing to the development of evidence-based clinical guidelines.
Hypothesis Statement
In our study, we hypothesize that TKA with constrained prosthesis in Neuropathic Arthropathy of the Knee gives good functional outcomes and is not associated with a high number of complications.
Objectives
To evaluate the functional outcomes, complication rates, and clinical outcomes of total knee arthroplasty with constrained implants in patients with neuropathic arthropathy of the knee joint. Secondary objectives include evaluating the safety of TKA with constrained implants in patients with Neuropathic Arthropathy.
Type of Study: Descriptive
Population: All patients undergoing Total Knee Replacement with constrained prosthesis
Sample size: 25
Intervention: TKA with constrained prosthesis
Outcome measures
1) Knee Society Score (KSS): The scores will be measured at multiple follow-up intervals: Immediate Post operative, 1 month, 3 months, 6 months, and 12 months postoperatively
2) Western Ontario and McMaster University Osteoarthritis Index (WOMAC): The WOMAC scores will be measured at multiple follow-up intervals: Immediate Post operative, 1 month, 3 months, 6 months, and 12 months postoperatively.
3) Visual Analog Scale (VAS): Will be used to assess pain intensity, with measurements taken preoperatively and at various intervals postoperatively: Immediate Post operative ,1 month, 3 months, 6 months, and 12 months.
4) Hospital for Special Surgery (HSS) Knee Score: The scores will be measured at multiple follow-up intervals: Immediate Post operative, 1 month, 3 months, 6 months, and 12 months postoperatively
5) Range of Motion (ROM): Will be Measured in degrees preoperatively and at Immediate Post operative, 1 month, 3 months, 6 months, and 12 months
6) Joint Stability: Evaluates the stability of the knee joint before and after surgery. This will be assessed Immediate Post operative,1 month, 3 months, 6 months, and 12 months postoperatively
7) Joint Effusion, Swelling, and Tenderness: will be evaluated at Immediate Post operative,1 month, 3 months, 6 months, and 12 months postoperatively.
Timeline
2018-2023
Statistical analysis
Both descriptive and inferential statistics will used to evaluate the outcomes of Total Knee Arthroplasty (TKA) in patients with neuropathic arthropathy. The sample size of 25 patients is determined based on the inclusion criteria for cases from 2018 to 2023, including both retrospective and prospective data.
Primary outcomes, such as changes in range of motion (ROM) and pain scores (Visual Analog Scale, VAS), will be analyzed using paired t-tests to compare preoperative and postoperative values, with a p-value of <0.05 indicating statistical significance. The Kaplan-Meier method will be used to estimate implant survival free from aseptic and any revision at 5 and 10 years.
Secondary outcomes, including functional scores (Knee Society Score, Hospital for Special Surgery scores) and complication rates, will also be analyzed using paired t-tests, while chi-square tests will be employed for categorical data like complications. Descriptive statistics (mean, median, standard deviation) will summarise patient demographics and clinical outcomes and provide a comprehensive assessment of the efficacy and safety of TKA with constrained prosthesis in this patient population.
Discussion
Total Knee Arthroplasty (TKA) with constrained prostheses offers good functional outcomes but is associated with a higher complication rate in patients with neuropathic arthropathy. It is well-supported by scientific evidence and clinical observations. Patients with neuropathic arthropathy have severe joint destruction, instability, and deformity due to underlying neuropathy. Joint reconstruction in these patients is a significant challenge. Constrained prostheses address these issues by providing increased stability when the surrounding soft tissues are compromised. However, the altered biomechanics, poor bone quality, and reduced proprioception in these patients increase the risk of complications such as aseptic loosening, dislocations, and infections. Previous studies have reported both improved function with constrained prostheses but a higher rate of complications. Our hypothesis proposes the idea that these implants can offer significant benefits in terms of pain relief and function and are not associated with a high rate of complications.
The study might face several challenges and limitations, including a small sample size, lack of a long-term follow-up, and potential biases inherent in the retrospective study component. The small sample size limits the generalizability of the findings, and the variability in patient characteristics, such as differing degrees of joint deformity and underlying neuropathic conditions, could introduce variability in outcomes. To mitigate these limitations, strict inclusion criteria will be used to create a more homogeneous sample representative of the broader patient population. Additionally, statistical adjustments, such as stratification based on severity and underlying conditions, will be applied to reduce the impact of confounding variables. The use of standardized outcome measures and consistent follow-up protocols will further ensure reliable and comparable data.
The study's findings hold important clinical relevance, particularly for managing patients with neuropathic arthropathy undergoing TKA. The observed benefits of constrained prostheses in improving knee function and reducing pain support their use in cases where traditional implants may fail due to joint instability and severe deformity. However, the high complication rate, as seen in other studies [2, 5, 6] suggests that clinicians must carefully balance these benefits against the risks, emphasizing the importance of thorough preoperative assessment and patient selection. The results advocate for a personalized approach to care, where the decision to use constrained prostheses is based on individual risk profiles, comorbidities, and functional needs. Additionally, the findings would provide a basis for refining postoperative management strategies, including enhanced monitoring for early complications and structured rehabilitation protocols. Overall, this study could contribute valuable insights that could improve surgical decision-making, enhance patient counselling, and potentially formulate standardized treatment guidelines for patient population.
Future research should focus on having a larger sample size to improve the generalizability of the findings. Long-term follow-up studies are also needed to understand the durability of constrained prostheses and the long-term impact on patients’ quality of life. Randomized controlled trials should be conducted to compare constrained prostheses with alternative implants or conservative management strategies. Investigating patient-specific factors that predict better outcomes and identifying risk factors associated with complications could help refine patient selection criteria and surgical planning. Additionally, exploring new implant designs, surgical techniques, or adjunctive therapies that could minimize complications while maintaining functional benefits would add value to the treatment protocols. This could further enhance the understanding and management of neuropathic arthropathy, ultimately leading to improved patient outcomes.
Conclusion
The hypothesis that Total Knee Arthroplasty (TKA) with constrained prostheses provides good functional outcomes but is not associated with a high complication rate in patients with neuropathic arthropathy is a crucial area of exploration that addresses a significant gap in medical knowledge and clinical practice. This study will contribute to understanding how constrained prostheses can be effectively used in cases where joint instability and severe deformity exist. These cohort of patients usually pose challenges to the usage of traditional implants. Through this study we could evaluate the risks involved, including complication rates, which are critical for guiding clinical decision-making.
By advancing knowledge of the benefits and limitations of using constrained prostheses in this unique patient population, the study supports a more nuanced, personalized approach to TKA, emphasizing careful patient selection and tailored surgical planning. The results of this study could lay the groundwork for future research, optimize postoperative management strategies, and potentially lead to the development of standardized treatment guidelines. Ultimately, this hypothesis and its exploration could play an essential role in advancing both the science and practice of treating neuropathic arthropathy, promoting better patient outcomes and contributing to the overall improvement of orthopedic care.
References
1. Charcot JM: Sur quelques arthropathies qui paraissent dépendre d’une lésion du cerveau ou de la moelle épinière. Arch Physiol Norm Pathol 1:161–178, 1868.
2. Tibbo ME, Chalmers BP, Berry DJ, Pagnano MW, Lewallen DG, Abdel MP: Primary total knee arthroplasty in patients with neuropathic (Charcot) arthropathy: contemporary results. J Arthroplasty 33(9):2815–2820, 2018.
3. Drennan DB, Fahey JJ, Maylahn DJ: Important factors in achieving arthrodesis of the Charcot knee. J Bone Joint Surg Am. 1971 Sep;53(6):1180-93.
4. Illgner U, van Netten J, Droste C, Postema K, Meiners T, Wetz HH: Diabetic Charcot neuroarthropathy of the knee: conservative treatment options as alternatives to surgery: case reports of three patients. Diabetes Care 37(6):e129–e130, 2014.
5. Kim YH, Kim JS, Oh SW: Total knee arthroplasty in neuropathic arthropathy. J Bone Joint Surg Br 84(2):329–336, 2002.
6. Bae DK, Song SJ, Yoon KH, Noh JH: Long-term outcome of total knee arthroplasty in Charcot joint: a 10- to 22-year follow-up. J Arthroplasty 24(8):1152, 2009.
7. Yoshino S, Fujimori J, Kajino A, Kiowa M, Uchida S: Total knee arthroplasty in Charcot's joint. J Arthroplasty 8(3):335, 1993.
8. Parvizi J, Marrs J, Morrey BF: Total knee arthroplasty for neuropathic (Charcot) joints. Clin Orthop Relat Res (416):145, 2003.
9. Zeng M, Xie J, Hu Y: Total knee arthroplasty in patients with Charcot joints. Knee Surg Sports Traumatol Arthrosc 24(8):2672, 2016.
10. Yang JH, Yoon JR, Oh CH, Kim TS: Primary total knee arthroplasty using rotating-hinge prosthesis in severely affected knees. Knee Surg Sports Traumatol Arthrosc 20(3):517, 2012.
11. Soudry M, Binazzi R, Johanson NA, Bullough PG, Insall JN: Total knee arthroplasty in Charcot and Charcot-like joints. Clin Orthop Relat Res 208:199–204, 1986.
13. Fullerton BD, Browngoehl LA: Total knee arthroplasty in a patient with bilateral Charcot knees. Arch Phys Med Rehabil 78(7):780–782, 1997.
14. Lambert AP, Close CF: Charcot neuroarthropathy of the knee in Type 1 diabetes: treatment with total knee arthroplasty. Diabet Med 19(4):338–341, 2002.
16. Babazadeh S, Stoney JD, Lim K, Choong PF: Arthroplasty of a Charcot knee. Orthop Rev (Pavia) 2(2):e17, 2010.
18. Rosenbaum AJ, DiPreta JA: Classifications in brief: Eichenholtz classification of Charcot arthropathy. Clin Orthop Relat Res 473(3):1168–117, 2015.
19. Chun KC, Kweon SH, Jeong KJ, Kim KM, Chun CH: The fate of allogeneic femoral head bone grafts using varus-valgus constrained total knee arthroplasty in neuropathic joints. J Arthroplasty 31(12):2778–2783, 2016.
20. Kucera T, Urban K, Sponer P: Charcot arthropathy of the knee. A case-based review. Clinical Rheumatology 30(3):425, 2011.
21. Patel A, Saini AK, Edmonds ME, Kavarthapu V: Diabetic neuropathic arthropathy of the knee: two case reports and a review of the literature. Case Rep Orthop 23:9301496, 2018.
22. Koshino T: Stage classifications, types of joint destruction, and bone scintigraphy in Charcot joint disease. Bulletin of the Hospital for Joint Diseases Orthopaedic Institute 51(2):205, 1991.
23. Eichenholtz SN: Charcot Joints. Charles C. Thomas: Springfield, IL, USA, 1966.
| How to Cite this Article: Mutha A, Sancheti P, Gugale S, Patil K, Sonawane D, Shyam A. Total Knee Arthroplasty with Constrained Implants in Patients with Neuropathic Arthropathy of the Knee Provides Good Functional Outcomes, and is Not Associated with a High Rate of Complications. Journal Medical Thesis 2024 January-June ; 10(1):46-49. |
Download Full Text PDF | Full Text HTML
Tailoring Total Knee Prostheses to Indian Anatomy: A Hypothesis on Improved Fit, Function, and Longevity
Vol 8 | Issue 2 | July-December 2022 | page: 16-20 | Pavan Soni, Parag Sancheti, Kailas Patil, Sunny Gugale, Sahil Sanghavi, Yogesh Sisodia, Obaid UI Nisar, Darshan Sonawane, Ashok Shya
https://doi.org/10.13107/jmt.2022.v08.i02.190
Author: Pavan Soni [1], Parag Sancheti [1], Kailas Patil [1], Sunny Gugale [1], Sahil Sanghavi [1], Yogesh Sisodia [1], Obaid UI Nisar [1], Darshan Sonawane [1], Ashok Shyam [1]
[1] Department of Orthopaedics, Sancheti Institute of Orthopaedics and Rehabilitation, Pune, Maharashtra, India.
Address of Correspondence
Dr. Darshan Sonawane,
Department of Orthopaedics, Sancheti Institute of Orthopaedics and Rehabilitation, Pune, Maharashtra, India.
E-mail: researchsior@gmail.com
Abstract
Background: Total knee replacement reliably relieves pain and restores mobility, but successful outcomes depend on how well implanted components match native bone geometry. Small differences between implant footprints and patient anatomy—particularly between mediolateral width and anteroposterior depth—can cause component overhang or under-coverage. Even millimetre-scale mismatches may irritate surrounding soft tissues, disrupt patellar tracking and reduce comfort during activities such as squatting, kneeling and rising from the floor. These practical, often subtle mismatches matter most in communities where deep-flexion activities are a routine part of daily life.
Hypothesis: We propose that knees in the studied Indian cohort show consistent differences in ML/AP relationships compared with the dimensional ladders used by many common implant systems. When sizing is guided mainly by AP measures, these differences will produce frequent ML under-coverage in smaller components and ML overhang in larger ones. Sex-based morphology is expected to amplify mismatch in women, while implants developed with regional anthropometry in mind should demonstrate closer fit and reduce intraoperative compromise. Better geometric concordance should lessen soft-tissue irritation and improve early function.
Clinical importance: Understanding local knee anthropometry enables surgeons to make pragmatic intraoperative choices and helps hospitals stock implants that reduce the need for compromise. By deliberately assessing ML coverage during trialling and keeping options such as asymmetric trays, finer size increments or augmentation strategies available, surgical teams can decrease soft-tissue irritation and better meet patients’ functional expectations. Thoughtful inventory planning informed by local data can shorten operative time, reduce waste and improve patient satisfaction without large additional cost.
Future research: Future research should focus on linking the small, millimetre-level mismatches we measure in the operating room to how patients actually feel and function afterwards. That means prospective studies that collect validated patient-reported outcomes and objective measures (range of motion, kneeling comfort, and return to daily activities) alongside the morphometric data. Randomized or registry-based comparisons of regionally adapted implants versus standard systems — with parallel cost-effectiveness analyses — will show whether better geometric fit produces real-world benefits.
Keywords: Total knee arthroplasty, Anthropometry, Implant sizing, Mediolateral overhang, Patellofemoral mechanics
Background
Total knee arthroplasty (TKA) has transformed the care of end-stage knee arthritis by reliably reducing pain and restoring mobility for large numbers of patients worldwide. Early implant designs offered limited sizing and geometry choices and were modeled largely on Western anthropometry, but as surgeons began to apply these implants across diverse populations they noted recurring mismatches between implant footprints and native bone geometry. Awareness of those mismatches prompted systematic anthropometric work to quantify the problem and to propose design or selection remedies. [1]
Anthropometric mismatch matters because small differences in component shape and size can have outsized clinical effects. Mediolateral (ML) overhang beyond a few millimetres can impinge soft tissues, provoke localized pain, and disrupt patellar tracking; conversely, under-coverage exposes cancellous bone, changes load distribution, and may accelerate wear or bone remodelling. Early morphometric studies therefore focused on basic planar measures — femoral ML and AP dimensions, tibial ML and AP widths, patellar thickness — and their derived aspect ratios, since these numbers directly inform tray footprints and femoral component geometry. [2]
Subsequent studies emphasized that population and sex differences are real and clinically relevant. Investigations from East and Southeast Asia documented smaller absolute dimensions and distinct ML/AP relationships compared with Western cohorts, prompting calls for population-tuned sizing ladders or gender-specific options. [3–6] Three-dimensional imaging and intraoperative series reinforced that the knee’s shape does not scale linearly with size: aspect ratios change across the size spectrum in ways that a fixed implant aspect ratio cannot mirror. [5,7] These findings were replicated across Chinese, Korean, Thai and Middle Eastern series, producing a consistent message — modern implants must either accept some degree of anatomical compromise or evolve to offer finer gradations and asymmetric options. [4–9]
Gender differences add another layer. Multiple investigators documented systematic differences in femoral morphology between men and women — females often present with relatively narrower ML widths for similar AP dimensions — introducing a risk of overhang if AP dimension alone dictates sizing. This observation led some manufacturers to introduce gender-targeted components; however, clinical trials and meta-analyses have produced mixed evidence on whether gender-specific designs yield meaningful outcome advantages. [10–13]
Practical implications go beyond pure geometry. In many Asian populations, functional expectations include deep flexion activities such as kneeling, squatting and floor seating; implants that seem adequate on standard radiographs may still fail to meet these real-world demands if they alter patellofemoral mechanics or introduce soft-tissue irritation. Thus, anthropometric mismatch influences not only implant survival but also patient satisfaction and day-to-day function. [6, 11]
Industry responses have varied: some companies refined sizing increments, introduced asymmetric tibial trays, or marketed gender-specific lines; others continued with broad, conservative ladders and advocated surgical techniques to adapt standard components. Comparative inventories and in-hospital stocking strategies increasingly rely on local anthropometric evidence to minimize intraoperative compromise. Large registry and international surveys underscored the heterogeneity of practice and the potential value of region-specific data to guide procurement and surgical planning. [14–16]
Taken together, the literature supports a practical, surgeon-centred approach: measure and understand local anthropometry, maintain flexible inventories that contain sizes and geometries suited to the served population, and apply intraoperative judgement when templating and trialling components. This body of work also sets a research expectation: to move from descriptive morphometry to prospective studies that link millimetre-scale mismatch to validated patient-reported outcomes and objective function. [17–19]
Hypothesis
Primary hypothesis
the anatomic dimensions of the knees in the studied Indian cohort will show systematic differences from those encoded in commonly used implant size ladders, producing predictable ML under-coverage in smaller components and ML overhang in larger ones when AP dimension alone dictates size selection. This mismatch is expected to be measurable and frequent enough to warrant reconsideration of inventory and sizing strategy. [1–4]
Mechanistic rationale
Implant manufacturers historically optimized designs around datasets that reflect specific populations; consequently, many widely used systems embed implicit assumptions about aspect-ratio trajectories across sizes. If those assumptions differ from the true, continuous distribution of patient anatomy in a different population, AP-based sizing will create ML discordance. The resulting geometric mismatch perturbs soft tissues, modifies patellofemoral relationships, and alters load transfer — plausible mechanistic pathways that can produce pain, impaired function and possibly altered wear behaviour. [2, 5, 7]
Secondary hypotheses
1. Sex differences will amplify mismatch patterns. For comparable AP dimensions, female knees will frequently show narrower ML widths (or different aspect ratios) than male knees; when implants are scaled by AP alone this will produce systematic overhang or edge prominence in females, consistent with prior comparative morphometry studies. [10–13]
2. Regional or locally manufactured implant systems that were designed with regional anatomy in mind will demonstrate closer dimensional concordance with the cohort than systems developed primarily from Western datasets; if true, privileging such systems in stock selection could reduce intraoperative compromise. [3,14]
3. Even millimetre-scale mismatches will be clinically meaningful: ML overhang exceeding commonly-cited thresholds (≈3 mm) will be frequent enough to influence postoperative comfort and early function, justifying changes to sizing practice and inventory policy. [18,19]
Operational implications of the hypotheses
If these hypotheses hold, several straightforward actions follow. Surgeons should not rely solely on AP templating but should routinely verify ML fit during trialling and be prepared to alter strategy (downsizing, alternate geometry, or modular options). Hospitals should base implant procurement on local anthropometric evidence, emphasizing implant systems and size ranges that reduce the need for intraoperative trade-offs. Finally, manufacturers should consider region-aware sizing ladders, asymmetric tibial trays and finer size increments to better match real anatomy. Together, these steps would be expected to reduce immediate postoperative soft-tissue irritation and potentially improve patient satisfaction for activities that demand deep flexion. [14–17]
Discussion
The aggregate literature and clinical experience show a persistent and practical problem: implants do not perfectly match human knees, and mismatch has predictable forms tied to population and sex differences. When AP measurement is prioritized, the implant ML dimension becomes the critical variable determining fit — and if the implant aspect-ratio curve diverges from the patient’s, overhang or under-coverage results. That phenomenon explains why surgeons in diverse regions routinely report the same set of intraoperative dilemmas: choosing between AP-matched components that overhang ML, or ML-matched options that create AP mismatch with risks of anterior notching or altered flexion space. [2, 5, 7]
Regional series repeatedly highlight smaller absolute dimensions and different aspect-ratio trends in Asian populations relative to Western datasets, and some local implant designs attempt to close that gap. Evidence shows that locally-tuned systems may fit better in specific subgroups, but the relationship between improved geometric fit and long-term clinical benefit is not definitively proven — randomized, long-term, comparative outcome studies remain scarce. Meanwhile, meta-analyses suggest that gender-specific designs do not consistently confer superior outcomes, underscoring that geometry alone is not the only determinant of success. Other variables — surgical technique, alignment philosophies, soft-tissue balancing, and rehabilitation — remain critical. [11–13, 14]
From a pragmatic standpoint, these insights shape three domains of action. First, the surgeon’s intraoperative algorithm should explicitly consider ML coverage as a decision point: accept minor ML mismatch only after weighing its likely impact on soft tissues and patellar mechanics, and use available technical options (downsizing with posterior augmentation, alternate trays, asymmetric options) when mismatch threatens function. Second, hospital procurement should be guided by local anthropometry: stocking implants that have demonstrated closer local fit reduces the frequency of unfavorable trade-offs and may improve operating efficiency. Third, industry should be encouraged to provide finer size increments and asymmetric tibial trays where feasible; modern manufacturing techniques make such options increasingly practical, though economic analyses are required. [14–17, 20]
Limitations and perspectives
while morphometric mismatch is well described, translating tight geometric concordance into consistent, measurable patient benefit requires prospective outcome data. Several observational studies link ML overhang to early soft-tissue complaints, but confounding variables and the multifactorial nature of postoperative pain complicate causal inference. Large-scale registries and randomized trials that pair geometric data with validated patient-reported outcome measures and long-term survivorship would provide the strongest evidence to motivate industry-level redesign. [18–21]
Finally, cultural and functional context matters. In populations where deep flexion and kneeling are essential for daily life, small geometric mismatches can disproportionally affect perceived outcome even if implant survival is acceptable. Surgeons and policy makers should therefore weigh local functional expectations when assessing the value of design modifications or inventory changes. [6, 12, 16]
Clinical importance
Understanding local knee anthropometry directly affects patient care. Appropriate implant selection and intraoperative sizing reduce the risk of soft-tissue irritation, patellofemoral maltracking and discomfort during culturally important activities like squatting and kneeling. For surgical teams, anthropometry informs operative choices (size selection, re-cutting strategy, choice of asymmetric or modular components) and inventory planning. For hospitals and purchasers, stocking implants that better mirror local anatomy can decrease intraoperative compromises, improve patient satisfaction, and potentially shorten revision risk related to early mechanical irritation. These considerations combine patient comfort, functional expectations and health-economics into a persuasive argument for region-aware practice.
Future directions
Future work must prospectively link millimetre-scale geometric mismatch to validated patient-reported outcomes and objective function, ideally through randomized or registry-based studies. Comparative trials of locally-tuned versus standard implants, paired with cost-effectiveness analyses, will clarify whether design refinements justify higher procurement costs. Exploration of modular and patient-matched manufacturing methods may offer scalable solutions, but their adoption should follow evidence of functional and economic advantage.
Conclusion
Knee anthropometry varies by population and sex, and those variations produce predictable implant-bone mismatches when AP-driven sizing is used without attention to ML coverage. The practical consequence is a set of intraoperative decisions that directly influence early comfort and long-term function, particularly in populations that demand deep flexion. Surgeons and hospitals should use local anthropometric evidence to guide implant selection, maintain flexible inventories, and apply intraoperative strategies that prioritize both geometric fit and biomechanical function. Manufacturers should consider regionally informed sizing ladders and asymmetric options; most importantly, the community needs prospective outcome studies to link geometric concordance to clinically meaningful benefits.
References
1. Vaidya SV, Ranawat CS, Aroojis A, Laud NS. Anthropometric measurements to design total knee prostheses for the Indian population. J Arthroplasty. 2000; 15(1):79–85.
2. Hitt K, Shurman JR, Greene K, McCarthy J, Moskal J, Hoeman T, Mont MA. Anthropometric measurements of the human knee: correlation to the sizing of current knee arthroplasty systems. J Bone Joint Surg Am. 2003; 85(suppl_4):115–22.
3. Barroso MP, Arezes PM, da Costa LG, Miguel AS. Anthropometric study of Portuguese workers. Int J Ind Ergon. 2005; 35(5):401–10.
4. Dai S, Surendran S. Morphometry of the proximal tibia to design the tibial component of total knee arthroplasty for the Korean population. The Knee. 2007; 14:295–300.
5. Cheng FB, Ji XF, Lai Y, Feng JC, Zheng WX, Sun YF, Fu YW, Li YQ. Three-dimensional morphometry of the knee to design the total knee arthroplasty for Chinese population. The Knee. 2009; 16(5):341–7.
6. Chaichankul C, Tanavalee A, Itiravivong P. Anthropometric measurements of knee joints in Thai population: correlation to the sizing of current knee prostheses. The Knee. 2009; 18(1):5–10.
7. Yue B, Varadarajan KM, Ai S, Tang T, Rubash HE, Li G. Differences of knee anthropometry between Chinese and white men and women. J Arthroplasty. 2011; 26(1):124–30.
8. Chin PL, Tey TT, Ibrahim MY, Chia SL, Yeo SJ, Lo NN. Intraoperative morphometric study of gender differences in Asian femurs. J Arthroplasty. 2011;26(7):984–8.
9. Ha CW, Na SE. The correctness of fit of current total knee prostheses compared with intra-operative anthropometric measurements in Korean knees. J Bone Joint Surg Br. 2012; 94(5):638–41.
10. Kurtz SM, Ong KL, Lau E, Widmer M, Maravic M, Gómez-Barrena E, et al. International survey of primary and revision total knee replacement. Int Orthop. 2011; 35(12):1783–9.
11. Cheng T, Zhu C, Wang J, Cheng M, Peng X, Wang Q, Zhang X. No clinical benefit of gender-specific total knee arthroplasty: systematic review and meta-analysis. Acta Orthop. 2014; 85(4):415–21.
12. Al-Arfaj AS, Alballa SR, Al-Saleh SS, et al. Knee osteoarthritis in Al-Qaseem, Saudi Arabia. Saudi Med J. 2003; 24(3):291.
13. Hafez MA, Sheikhedrees SM, Saweeres ES. Anthropometry of Arabian arthritic knees: comparison to other ethnic groups and implant dimensions. J Arthroplasty. 2016; 31(5):1109–16.
14. Kim TK, Phillips M, Bhandari M, Watson J, Malhotra R. What differences in morphologic features of the knee exist among patients of various races? A systematic review. Clin Orthop Relat Res. 2017; 475(1):170–82.
15. Fan L, Xu T, Li X, Zan P, Li G. Morphologic features of the distal femur and tibial plateau in Southeastern Chinese population: a cross-sectional study. Medicine (Baltimore). 2017; 96(46).
16. Rahmadian R, Rachman S, Putra FD, Wijaya R. Knee Anthropometry Using MRI and Its Suitability with Three Implant Brands in Semen Padang Hospital Indonesia. (2019).
17. Karimi E, Zandi R, Norouzian M, Birjandinejad A. Correlation of anthropometric measurements of proximal tibia in Iranian knees with size of current tibial implants. Arch Bone Jt Surg. 2019; 7(4):339.
18. McArthur J, Makrides P, Thangarajah T, Brooks S. Tibial component overhang in total knee replacement: incidence and functional outcomes. Acta Orthop Belg. 2012; 78(2):199–202.
19. Zalzal P, Backstein D, Gross AE, Papini M. Notching of the anterior femoral cortex during total knee arthroplasty: characteristics that increase local stresses. J Arthroplasty. 2006; 21(5):737–43.
20. Insall JN, Binazzi R, Soudry M, Mestriner LA. Total knee arthroplasty. Clin Orthop Relat Res. 1985 ;( 192):13–22.
21. Hungerford DS, Krackow KA. Total joint arthroplasty of the knee. Clin Orthop Relat Res. 1985 ;( 192):23.
| How to Cite this Article: Soni P, Sancheti P, Patil K, Gugale S, Sanghavi S, Sisodia Y, Nisar OUI, Sonawane D, Shyam A. Tailoring Total Knee Prostheses to Indian Anatomy: A Hypothesis on Improved Fit, Function, and Longevity. Journal of Medical Thesis. 2022 July-December; 08(2):16-20. |
Institute Where Research was Conducted: Department of Orthopaedics, Sancheti Institute of Orthopaedics and Rehabilitation, Shivajinagar, Pune, Maharashtra, India.
University Affiliation: MUHS, Nashik, Maharashtra, India.
Year of Acceptance of Thesis: 2020
Full Text HTML | Full Text PDF




